US2006199774A1PendingUtilityA1

Remedies

Assignee: OHNOGI HIROMUPriority: Apr 10, 2001Filed: Apr 24, 2006Published: Sep 7, 2006
Est. expiryApr 10, 2021(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/30A61P 25/00A61P 25/28A61P 25/16A61P 25/02A61P 27/02C07H 17/04A61K 31/7048C07H 17/075A61K 31/366A23K 20/163A61K 31/37A23L 33/105A23K 20/116
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a medicament, a food, a beverage or a feed, each comprising as an effective ingredient a compound having an enhancing action for NGF production, which is effective for a treatment, an amelioration of symptom, prevention or the like of a disease requiring enhancement of NGF production, wherein the compound has a coumarin and/or chroman backbone. Since no toxicity is especially found in the effective ingredient of the present invention, and there is no risk of incidence of adverse actions, the treatment or the like of the above disease can be safely and appropriately carried out.

Claims

exact text as granted — not AI-modified
1 . A method for enhancing nerve growth factor production, said method comprising administering to an animal at least one isolated or purified compound selected from the group consisting of a compound having a coumarin backbone, a compound having a 2-dimethyl chroman backbone, and pharmacologically acceptable salts thereof.  
     
     
         2 . The method according to  claim 1 , wherein the compound having the coumarin backbone is represented by the general formula (I):  
       
         
           
           
               
               
           
         
         wherein each of R 1 , R 2  and R 3  is a hydrogen atom, hydroxyl group, an aliphatic group, an aromatic group, an aromatic-aliphatic group or a saccharide residue, which may be identical or different;  
         or the compound having the coumarin backbone is represented by the general formula (II):  
         
           
             
             
                 
                 
             
           
         
         wherein each of R 4  and R 5  is a hydrogen atom, hydroxyl group, an R i O group, an R ii COO group, R i  and R ii  being an aliphatic group or an aromatic group, or a saccharide residue, which may be identical or different.

Join the waitlist — get patent alerts

Track US2006199774A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.